Edition:
United Kingdom

Odonate Therapeutics Inc (ODT.OQ)

ODT.OQ on NASDAQ Stock Exchange Global Select Market

25.33USD
6:28pm BST
Change (% chg)

$-0.17 (-0.67%)
Prev Close
$25.50
Open
$25.57
Day's High
$25.75
Day's Low
$25.11
Volume
3,932
Avg. Vol
25,528
52-wk High
$31.75
52-wk Low
$15.15

Chart for

About

Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients... (more)

Overall

No Ratios Available.

Financials

  ODT.OQ Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -- -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.08

BRIEF-Odonate Therapeutics Q4 Loss Per Share $0.81

* ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2017

14 Feb 2018

Earnings vs. Estimates